Elia, A. M., Saldain, L., Vanzulli, S., Helguero, L. A., Lamb, C. A., Fabris, V. T., . . . Lanari, C. L. M. (2022). Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial. Web
Citación estilo ChicagoElia, Andres Maximiliano, et al. Beneficial Effects of Mifepristone Treatment in Patients With Breast Cancer Selected By the Progesterone Receptor Isoform Ratio: Results From the MIPRA Trial. 2022.
Cita MLAElia, Andres Maximiliano, et al. Beneficial Effects of Mifepristone Treatment in Patients With Breast Cancer Selected By the Progesterone Receptor Isoform Ratio: Results From the MIPRA Trial. 2022.
Precaución: Estas citas no son 100% exactas.